Collaborations Pharma
Collaborations Pharmaceuticals, Inc. is a privately owned company focused on research and development of innovative therapeutics for rare and neglected diseases. They leverage artificial intelligence (AI) software for drug discovery, toxicology assessment, and the design of new molecules with desired properties. Their software is applicable to pharmaceutical, consumer product, and other chemistry-intensive industries. The company has a proven track record of securing funding, having raised over $23.5M in grants since 2016 from agencies like NIH, DOD, and DTRA. They offer their software through licensing and fee-for-service models, aiming to accelerate the development of life-changing treatments. The company highlights its expertise in machine learning and drug discovery, with a focus on advancing care for rare diseases like Batten disease.
Collaborations Pharma
Collaborations Pharmaceuticals, Inc. is a privately owned company focused on research and development of innovative therapeutics for rare and neglected diseases. They leverage artificial intelligence (AI) software for drug discovery, toxicology assessment, and the design of new molecules with desired properties. Their software is applicable to pharmaceutical, consumer product, and other chemistry-intensive industries. The company has a proven track record of securing funding, having raised over $23.5M in grants since 2016 from agencies like NIH, DOD, and DTRA. They offer their software through licensing and fee-for-service models, aiming to accelerate the development of life-changing treatments. The company highlights its expertise in machine learning and drug discovery, with a focus on advancing care for rare diseases like Batten disease.